TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization June 22, 1990